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Measles virus undergoes error-prone replication like
other RNA viruses, but over time, it has remained
antigenically monotypic. The constraints on the virus
that prevent the emergence of antigenic variants
are unclear. As a first step in understanding this
question, we subjected the measles virus genome
to unbiased insertional mutagenesis, and viruses
that could tolerate insertions were rescued. Only
insertions in the nucleoprotein, phosphoprotein,
matrix protein, as well as intergenic regions were
easily recoverable. Insertions in the glycoproteins
of measles virus were severely under-represented
in our screen. Host immunity depends on developing
neutralizing antibodies to the hemagglutinin and
fusion glycoproteins; our analysis suggests that
these proteins occupy very little evolutionary space
and therefore have difficulty changing in the face of
selective pressures. We propose that the inelasticity
of these proteins prevents the sequence variation
required to escape antibody neutralization in the
host, allowing for long-lived immunity after infection
with the virus.
INTRODUCTION
Measles virus (MeV) is an enveloped, single-stranded negative-
sense RNA virus of the genusMorbillivirus in the family Paramyx-
oviradae (Griffin et al., 2012). MeV enters a cell via the actions of
two surface glycoproteins, the hemagglutinin (H) and the fusion
protein (F) (Yanagi et al., 2006). H acts as the receptor binding
protein, whereas F is the actual fusogenic protein responsible
for mediating viral envelope and cell membrane fusion (Griffin,
2013). The cellular receptor for MeV is CD150/SLAM; however,
some strains (including vaccine strains) can also use the ubiqui-
tously expressed CD46 protein (Yanagi et al., 2009). Neutralizing
antibodies against MeV are thought to solely target the F and
H proteins, with H being the major neutralizing antigenic targetC(de Swart et al., 2005). Known to be vaccine preventable, both
vaccination and clinical infection confer long-lived immunity
(Anders et al., 1996; Moss and Griffin, 2006).
MeV has an error-prone RNA-dependent RNA polymerase
(RdRP) that in vitro has a mutation rate similar to that of other
RNA viruses (Drake, 1993; Parvin et al., 1986; Sanjua´n et al.,
2010; Schrag et al., 1999). Over a cycle of infection and transmis-
sion between humans, MeV is likely to be exposed to similar
selection pressures by the immune system as other respiratory-
transmitted viruses (Braciale et al., 2012; Griffin, 1995; Kohlmeier
and Woodland, 2009). Therefore, a priori, one might expect that
MeV would acquire sequence diversity in surface-exposed pro-
tein epitopes to evade the adaptive immune response. Certainly
this happenswithmany viruses, including influenza A virus. How-
ever, this antigenic ‘‘drift’’ does not appreciably occur in theMeV
F and H glycoproteins. The molecular basis for the lack of emer-
gent antigenically distinct strains of MeV, relative to other related
negative-sense RNA viruses like influenza A virus, is currently un-
clear (Fayolle et al., 1999; Lech et al., 2013; Xu et al., 2013). Given
thatMeVdoesnot undergomajor antigenic changes, it is possible
that the glycoproteins of MeV are under a rigid, but as of yet
undefined, constraint that prevents this evolution from occurring.
Previously, we reported a 15-nucleotide insertional mutagen-
esis on the influenza A virus genome (Heaton et al., 2013).
Most regions of the influenza A virus genome were found to be
resistant to insertion, but the head domain of the hemagglutinin
protein was identified as highly tolerant of transposon insertion.
We speculated that the observed mutational tolerance was
an experimental readout for evolutionary flexible protein do-
mains and that this flexibility was the underlying basis for the
rapid antigenic drift observed with influenza A virus. However,
we had no comparison to a virus that does not undergo rapid
antigenic evolution in its surface glycoproteins.
In this study, we sought to determine where in the antigenically
stable MeV genome insertions could be tolerated and, in partic-
ular, whether any insertions could be made in the glycoproteins.
By performing these experiments under standard cell culture
conditions, we asked where MeV had the potential to change
in the absence of immune selection. MutantMeVswith insertions
in distinct domains in the nucleoprotein (N), phosphoprotein (P),
and matrix protein (M), as well as some intergenic regions, wereell Reports 11, 1331–1338, June 9, 2015 ª2015 The Authors 1331
Figure 1. Insertional Mutagenesis of MeV Genome
(A)Mutant viruseswere rescued by transfectingBSR-T7 cells with the transposon library and then co-culturing the cells with A549 cells. The resulting viruseswere
passaged on A549 cells, and viral RNA was sequenced.
(B–D) The input library and both passageswere subjected to deep sequencing. The total sequencing coverage of the genome is shown on the left panels, whereas
the number of reads containing transposon insertions is indicated on the right. The numbers along the x axis of the graphs indicate the genomic nucleotide
position. The red bars under the genome diagrams in (B)–(D) indicate the individual RT-PCR products amplified for Illumina sequencing. Dashed lines indicate a
threshold of 0.01% of the total reads.viable. NoMeVs with insertions in either the F or H glycoproteins,
or in the large polymerase gene (L), were highly represented in
the screen. These data suggest that the MeV hemagglutinin
and fusion proteins are very rigid when compared to the influ-
enza A virus hemagglutinin under essentially the same experi-
mental conditions. We hypothesize that this inelasticity may be
a contributor to the observed lack of MeV antigenic variation.
RESULTS
Construction andRescueof theMeVTransposonLibrary
As a test of viral rescue efficiency, a modified Edmonston strain
MeV genomic construct expressing GFP was transfected into
BSR-T7 cells with four accessory helper plasmids (Figure S1A).
The transfected cells were then co-cultured with permissible
human adenocarcinoma alveolar basal epithelial cells (A549s).
Passage of viruses on A549s caused large GFP-positive syncytia
to form only if all helper plasmids were added to the transfection
(Figure S1B). Recovery of infectious particles was high, with the1332 Cell Reports 11, 1331–1338, June 9, 2015 ª2015 The Authorsviral titer of MeV GFP after co-culture at 5.2 3 103 TC ID50/ml
(Figure S1C).
To generate a high-coverageMeVmutant library, the genome-
containing plasmid was mutagenized in vitro with Mu transpo-
sase and an artificial transposon with a kanamycin selectable
marker as previously described (Heaton et al., 2013). The
mutagenesis was scaled to generate >105 individual inser-
tional mutants, which would represent >5-fold coverage of the
possible insertion positions. The template for the mutagenesis
was a ‘‘MeV+3’’ genomic construct, which does not encode
GFP and has an extra three-nucleotide stop codon behind the
original stop codon of N (Figure S1D). After mutagenesis and
removal of the transposon body, a 15-nt insert remains in the
genome (ten of which serve as a unique molecular tag), making
the antigenome once again follow the rule of six required by
paramyxoviruses (Kolakofsky et al., 1998) (Figure S1E).
To determine where MeV could tolerate insertions, multiple
independent rescues of the mutant libraries were performed
(Figure 1A). Five days post-transfection, the cells were pooled
and co-cultured with A549s for 3 days to propagate rescued
viruses. After co-culture, both supernatant and cell-associated
viruses were collected and passaged on fresh A549 cells to
select for fully infectious virus mutants (passage 1). The propa-
gated viruses from passage 1 were passaged 72 hr post-infec-
tion onto fresh A549 cells for passage 2. RNA extracted from
the cells of both passages was subjected to RT-PCR with
MeV-specific primers that amplified the genome in six overlap-
ping segments. The subsequent cDNA was prepped and sub-
mitted for Illumina HiSeq next-generation sequencing.
Sequencing of our input library demonstrated there was good
sequencing coverage and insertions were evenly distributed
throughout theMeVgenome,with thevastmajorityofcodonscon-
taining an insertion (Figure 1B; Table S1). Although the genome of
the input library was evenly covered with transposons, only inser-
tions in distinct regions of the MeV genome were recovered after
selection (Figures 1C and 1D). Insertion sites in intergenic regions,
except those between the H and L genes, were readily recover-
able. Sites in the N, P, and M were also abundant. Despite select
regions of the MeV genome tolerating insertions, less than 1% of
total readswith insertionsweredetected in the F,H, or L genes. In-
sertions in the 50 and 30 distal un-translated regions (UTRs) of the
genomewerealsoonly rarely recovered. Thesedataare represen-
tative of three independent rescue and passaging experiments.
MeV Surface Glycoproteins Are Intolerant of Insertional
Mutagenesis
Analyzing the abundance of insertions across the passages
showed that all sites had relatively the same abundance in the
input library but were recovered with varying efficiencies (Fig-
ure 2A). Viruses rescued in the first round of passaging were
generally carried through to the second round in similar propor-
tions, although some were lost or greatly reduced due to addi-
tional selection (Figure 2A). We next normalized the percentage
of insertions to the size of each genomic region (Figure 2B).
The N/P, P/M, and M/F intergenic regions were greatly enriched
compared to open reading frames. Although enrichment is
seen in N, P, and M, few insertions are seen in the H/L intergenic
region or the F, H, and L ORFs.
To validate the screen data, the top insertion sites were cloned
into a MeV+3 GFP construct (Figure 2C), rescued, and sequence
verified. All of these viruses were easily rescued and formed
syncytia on A549 cells similar to the parental virus (Figure 2D;
Table 1). The top hits in F, F/H, H, H/L, and L in our screen were
also cloned despite the fact that our analysis predicted that they
would be significantly attenuated. No viruses were rescuable
from the top insertion sites in L and in F (Figure 2D; Table 1). Inser-
tions in sites in the F/H and H/L intergenic regions as well as in
H were detectable by fluorescence microscopy after rescue, but
viral titer was almost undetectable (Figure 2D; Table 1). Growth
curveswere then performed onA549 cellswith a panel of rescued
viruses that grew to sufficiently high titers in the N, P, P/M,M, and
M/F regions. We were unable to obtain high-titer viral stocks of
H or F protein mutants, so these viruses were excluded from our
growth curve analysis. The insertional mutants predicted by our
analysis to be viable had only minor attenuation (less than
1log10 of TCID50) in multicycle growth relative to the parental
MeV (Figure 2E). Therefore, we conclude that the abundance ofCan insertionalmutant detected in our sequencing data is generally
correlated with the fitness of the mutant virus.
Analysis of Insertional Mutagenesis of Other RNA
Viruses Reveals Exceptional Intolerance of the MeV F
and H Glycoproteins
In order to put our MeV insertional mutagenesis into perspective,
we took advantage of previously published data sets and
analyzed the transposon insertional profiles of influenza A virus
(Heaton et al., 2013), hepatitis C virus (HCV) (Remenyi et al.,
2014), and Venezuelan equine encephalitis virus (VEEV) (Beitzel
et al., 2010) along with our current study on MeV. As each
study was performed slightly differently, we plotted each virus
individually with each genomic region assigned a value out of
a maximum of 1 to show the relative tolerance to insertion.
Whereas we observed general consensus on some genomic
areas, i.e., polymerase proteins tolerate very few insertions, we
observed highly divergent results across the different viral sur-
face glycoproteins responsible for attachment and entry. At one
end of the spectrum, the influenza A virus hemagglutinin (HA),
and specifically theHA1domain,which encodes the head region,
was the most mutable gene in the entire genome (Figure 3A and
inset). VEEV and HCV accepted some insertions in the function-
ally similar envelope glycoproteins (E2/E1 and E1/E2, respec-
tively) but to a lesser extent than influenza A virus (Figures 3B
and 3C). For the HCV E2 glycoprotein, insertions were for the
most part limited to the N-terminal hyper-variable region 1
(HVR1) (Hijikata et al., 1991); when analyzed alone, in fact, the
HVR1 becomes the second most-tolerant region in the entire
genome (Figure 3C, inset). In contrast to the other viruses, strik-
ingly, theMeVF andHglycoproteinswere among themost trans-
poson-intolerant genes in the entire MeV genome (Figure 3D).
DISCUSSION
MeV is an antigenically monotypic virus. We began this study in
an attempt to gain insight into themolecular basis underlying that
phenomenon. Mutagenesis revealed that certain domains of
the genome can tolerate insertions. In particular, the intergenic
regions toward the 50 end of the genome were highly enriched
for insertions. In addition, certain regions of N, P, and the M
genes were also tolerant of mutations. No domains in the glyco-
proteins or the polymerase genes tolerated insertions, likely due
to the effects of the insertion on the structure and therefore func-
tion of the gene products.
It is well known that theC terminus of theN protein is one of the
most-variable regions across MeV isolates (Xu et al., 1998), with
variability also frequently observed in the P gene (Baczko et al.,
1992; Bankamp et al., 2008). Previous reports have also shown
that MeVs not expressing the M protein, characteristic during
subacute sclerosing panencephalitis (SSPE) infections, are
viable in vitro (Cathomen et al., 1998). Therefore, it is not surpris-
ing that viral mutants with insertions in these genes were
frequently recovered during this screen.
Previous studies have shown that the insertion of GFP into the
MeV L (Duprex et al., 2002) as well as insertions at the end of the
H protein (Hammond et al., 2001; Nakamura et al., 2005; Plem-
per et al., 2002; Schneider et al., 2000) are viable. We did notell Reports 11, 1331–1338, June 9, 2015 ª2015 The Authors 1333
Figure 2. MeV Glycoproteins and Polymerase Genes Are Intolerant of Insertions
(A) Plots representing individual insertion sites. Individual viruses in the input and the passages are represented by different colors; the thickness of the lines is
representative of the proportion in the population. The MeV genomes are drawn either to scale (I), distorted to represent the actual coverage of insertions in the
input (II), or distorted to represent the total percentage of reads in each region after the second passage (III).
(B) Percent of reads in a region divided by the size of that region to give the fold over predicted values (as if there was no biological selection). Under-represented
areas are displayed as negative values (red) whereas over-represented areas are displayed as positive values (green).
(C) Individual insertion sites were cloned into a MeV+3 GFP construct to validate the sequencing results. 23 Stop indicates the presence of an additional stop
codon after the normal stop codon of the N gene.
(D) Top hits for the screen, plus the top hits for each region were cloned and rescued. For each panel title, the letter represents the genomic region whereas the
number represents the genomic nucleotide position preceding the insertion. The scale bar represents 400 mm.
(E) Growth curves of viruses with insertions in the indicated sites. Values and error bars represent the mean and SEM, respectively. Green filled circles and line,
parental MeV.
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Table 1. Verified Recoverable Transposon Insertion Sites
Genomic
Location
Genomic
Nucleotide
Position
Codon
Preceding
Insertion
Translation
of Insert
Rescue Titer
(Log Fold over
MeV +3)
N 1,654 515 IAAAPI +++
N 1,660 517 YAAAVY ++
N/P 1,720 NA NA ++
N/P 1,721 NA NA ++
N/P 1,725 NA NA ++
P/C/V 2,126 105 GAAATG ++
P/V 2,703 298 CGRTQ ++
P 3,329 506 NAAAMK ++
P/M 3,334 NA NA +
P/M 3,337 NA NA ++
M 4,048 202 GAAAPG ++
M 4,082 214 CGRTE +++
M/F 4,789 NA NA ++
M/F 4,801 NA NA ++
M/F 4,815 NA NA +++
M/F 4,826 NA NA ++
M/F 4,843 NA NA +
M/F 4,846 NA NA ++
F 6,442 330 MRPHSN -
F 6,953 500 IAAAYI -
F 7,035 528 CGRKG -
F/H 7,120 NA NA +
F/H 7,210 NA NA +
F/H 7,212 NA NA +
H 7,275 NA NA (start codon) +
H 7,355 27 VRPHRE +
H 8,697 474 SAAAPR -
H/L 9,153 NA NA -
H/L 9,163 NA NA +
H/L 9,193 NA NA +
L 11,507 757 CGRNL -
L 11,846 870 CGRSN -
L 14,740 1,834 DAAAVE -
Individual mutant viruses were rescued. The top insertion sites from the
screen are shown in the top half of the table. The top three insertion sites
in each region from F through L are shown in the bottom half of the table.
The titer over the background rescue of the MeV+3 GFP virus was calcu-
lated. +++,R2logs over background; ++,R1log over background; +,%1
log over background; -, no virus was detected. N/A indicates the insertion
was in a non-coding region.detect high levels of transposon insertions at those particular
locations in our study. This is likely a reflection of multiple
factors. First of all, the specific sequence of the insertion likely
contributes to the tolerance (or lack of tolerance) of the insertion.
Second, the experimental conditions like specific cell lines used
for growth of the virus may also change the acceptance of an
insertion. Finally, the competitive nature of our viral rescue
‘‘hides’’ some tolerated insertion sites. When all the mutantsCare rescued and passaged at the same time, only the most-fit
viruses are highly represented in the output sequencing. This
phenomenon can be observed in the H gene and H/L intergenic
region; these areas were significantly under-enriched for trans-
poson insertions in the screen, however, rescue of individual
mutants did show some viable (but highly attenuated) viruses
(Figure 2D; Table 1). Viral competition shrinking the representa-
tion of viable, but attenuated, mutants likely explains why the
H gene was devoid of transposons in our study, but variability
of H is observed in nature (Bellini and Rota, 1998). We therefore
utilize insertional mutagenesis as a readout of generally flexible
or inflexible regions of a viral genome, not a comprehensive list
of the specific locations that can tolerate insertions. This strategy
explores a phenotypic and fitness landscape that is not acces-
sible via normal processes of RdRP-dependent mutation and
reveals themost flexible or inflexible regions of theMeV genome.
Whereas wild-type viruses rarely have large insertions or dele-
tions, our data are consistent with the known features of extant
MeV strains. For example, distinct MeV strains isolated from
clinical infections contained additions in the 30 UTR of the M
gene and deletions in the F 50 UTR in the M/F intergenic region
(Bankamp et al., 2014). Our study showed that this intergenic
region contained the most-abundant number of transposons in
our screen, totaling 34% of all reads with insertions.
It is generally accepted that the high sequence diversity
frequently associated with RNA viruses is the result of rapid,
error-prone replication and strong selection pressures applied
by the immune system. However, these factors alone cannot
explain why such a large range of antigenic diversity is observed
across different RNA viruses. Despite similar viral polymerase
error rates and immune system pressures, virus diversity can
vary greatly, from antigenically monotypic viruses like MeV to
highly drifted viruses like influenza A virus. It stands to reason
that evolutionary constraints on the viral protein scaffolds them-
selves, on which the variation has to arise, could be the missing
molecular explanation.
We have provided evidence that, in fact, the glycoproteins of
MeV are intolerant of (or highly attenuated by) five amino-acid in-
sertions, which is a fairly significant mutational lesion. When we
compare our data set to other RNA virusesmutagenized with the
same technique, however, we find that the glycoproteins of
VEEV, HCV, and especially influenza A virus tolerate the same
five amino acid insertions to amuch-greater extent. It is currently
unclear why some viral glycoproteins have evolved to be rigid
whereas others remain flexible. One possibility is the nature of
the receptors utilized by the viruses. Influenza A virus requires
only a sialic acid moiety to act as a receptor (Skehel and Wiley,
2000) and is by far the most flexible surface glycoprotein. In
contrast, HCV, MeV, and VEEV all utilize at least one proteina-
ceous receptor (Lindenbach and Rice, 2013; Ludwig et al.,
1996; Yanagi et al., 2009), which likely put significant constraints
on how flexible the proteins can become. It is also worth noting
that the intergenic regions of MeV are highly tolerant to inser-
tions, which may appear to minimize the magnitude of the
insertions in the genes themselves. If we exclude the intergenic
regions from the analysis, however, the H and F proteins are
the second and third least-tolerant open reading frames in the
genome, respectively, after the L protein.ell Reports 11, 1331–1338, June 9, 2015 ª2015 The Authors 1335
Figure 3. Comparative Analysis Reveals MeV
Glycoproteins Are Exceptionally Resistant to
Insertional Mutation
The total number of sites that could tolerate in-
sertions in each region were normalized to region
size and graphed. Red columns indicate the major
viral surface glycoproteins.
(A) Influenza A virus. The HA1 head domain and HA2
stalk domain of the influenza A virus hemagglutinin
are separated in the insert.
(B) VEEV.
(C) HCV. The hyper-variable region 1 of E2 is sepa-
rated from the rest of the E2 protein in the insert.
(D) MeV. All values are out of an arbitrary value of 1.From a practical standpoint, this technology may allow the
prediction of antigenically invariant epitopes in viral proteins for
vaccine purposes. Previously, our research demonstrated the
HA2 conserved ‘‘stalk’’ region of the influenza A virus HA protein
was refractory to transposon mutagenesis whereas the head
region was very tolerant (Heaton et al., 2013). Work in the influ-
enza A virus vaccine field has found stalk-reactive antibodies
to be broadly neutralizing to influenza virus subtypes (Krammer
and Palese, 2013), due to a high degree of stalk domain conser-
vation. With respect to MeV, our data predict that the lack of an
evolutionary flexible domain in MeV H or F limits the antigenic
variation potential of the virus. This may be part of the reason
why the MMR live-attenuated vaccine remains effective against
currently circulating strains of MeV.
In summary, our data suggest that MeV is antigenically
conserved, at least in part, because the H and F proteins them-
selves are fundamentally unable to tolerate a large range of mu-
tations. This is in contrast to evolutionary flexible proteins like the
HA encoded by influenza A virus. The evolutionary constraints
imposed by the viral proteins themselves likely represent a key
parameter (along with intrinsic viral polymerase mutation rate)
in determining long-term viral diversity and potentially the effi-
cacy of a vaccine over long timescales.
EXPERIMENTAL PROCEDURES
Cells
The human alveolar basal epithelial cell (A549) and the baby hamster kidney
cell expressing T7 (BSR-T7) cell lines were maintained in DMEM containing
10% FBS by volume and penicillin/streptomycin (Invitrogen).
Generation of MeV Constructs and Viral Rescue
TheMeVGFP rescue systemwas generated by the lab of B.L. using theGFP-N
Edmonston antigenomic clone generously provided by W. Paul Duprex1336 Cell Reports 11, 1331–1338, June 9, 2015 ª2015 The Authors(Boston University; Duprex et al., 1999) and heterol-
ogous N, P, and L helper genes (a generous gift from
Richard Plemper, Georgia State University). See the
Supplemental Experimental Procedures for further
details.
To test the number of viruses we could rescue
from a single transfection, the MeV GFP genomic
construct was transfected into BSR-T7 cells
with four optimized plasmids expressing codon-
optimized T7 polymerase and the N, P, and L helper
genes as previously published (Krumm et al., 2013;
Radecke et al., 1995). The transfected cells wereco-cultured with permissible A549s. Cell-associated and free virus was titered
on A549 cells by 50% tissue culture infectious dose (TCID50) as described by
Reed and Muench (1938) (Figure S1C). Individual transposon mutant viruses
were rescued in a similar manner. Their cloning, rescue, and characterization
are fully described in the Supplemental Information.
Generation of MeV Mutant Libraries
A MeV+3 genomic construct suitable for mutagenesis was generated as
described in the Supplemental Information. The Mutation Generation System
(Fisher Scientific) was used to randomly insert transposons in the MeV+3
plasmid according to the manufacturer’s protocol (Figure S1E). Four indepen-
dent in vitro transposon insertion reactions were performed on 760 ng MeV+3
plasmid, which were then pooled and transformed into Stbl2 cells. Following
transformation, the cells were plated on 15-cm plates with LB agar containing
ampicillin and kanamycin and allowed to grow for 30 hr at 30C. The subse-
quent colonies were scraped and pooled. DNA was extracted from the pooled
colonies using a HiPure maxiprep kit (Invitrogen) and digested with NotI (New
England Biolabs) to remove the transposon body. The restricted plasmid was
then gel purified using the QIAquick kit (QIAGEN), and 1 mg of DNA was re-
ligated at 16C for 16 hr using T4 Ligase (New England Biolabs). The entire
ligation mixture was transformed into Stbl2 cells and plated on 15-cm plates
containing ampicillin and allowed to grow 30 hr at 30C. The colonies were
again pooled and the DNA was extracted using the HiPure maxiprep kit.
Viral Mutant Library Rescue
The mutant MeV library was rescued using standard protocols with modifica-
tions (Krumm et al., 2013; Radecke et al., 1995). 5 mg of MeV genome and four
helper plasmids were transfected into 70% confluent BSR-T7 cells in 6-well
dishes using the Lipofectamine LTX with Plus (Invitrogen) reagent. A total of
five 6-well plates were used for rescuing the viral libraries. At 16 hr post-trans-
fection, the media was replaced with fresh DMEM. Five days post-transfec-
tion, the transfected cells were scraped into their media, pooled, and then
co-cultured with 60% confluent A549s in 15-cm dishes. After 3 days of co-cul-
ture, the cells were again scraped into their media freeze thawed at80C and
pelleted by centrifugation 4,000 3 g for 5 min. The clarified supernatant was
used to infect 70% confluent A549s in 15-cm dishes. After 3 days (sufficient
time to allow high levels of viral replication to occur), the infected cells were
scraped into their media. Half of the cells were pelleted, lysed in 3 ml TRIzol,
and frozen at 80C. The remaining cells were freeze thawed and pelleted
by centrifugation (4,000 3 g for 5 min). The clarified supernatant was again
used to infect 70% confluent A549s for a second passage of 3 days in
15-cm dishes. After 3 days, the supernatant was removed and the infected
cells were lysed in 6 ml TRIzol and frozen at 80C.
RT-PCR and Illumina Sequencing
Samples in TRIzol were thawed, and RNA was extracted according to
manufacturer’s protocols. The MeV genomic RNA was then amplified in six
segments using overlapping primers sets as described in the Supplemental
Experimental Procedures with Invitrogen’s SuperScript III RT-PCR kit with
Platinum Taq. The cDNA segments from each sample were pooled in equal
molar amounts, sheared with Covaris sonication, and prepped for sequencing
using TruSeq DNA LT Sample Prep Kit (Illumina) according to the manufac-
turer’s instructions. Barcoded and multiplexed samples were sequenced on
a HiSeq2000 using 100-nt single-end reads in Rapid Run mode.
Analysis of Illumina Sequencing Data
Analysis of the transposon insertions was done as previously described
(Heaton et al., 2013). Please see the Supplemental Experimental Procedures
for details.
Meta-analysis of HCV, VEEV, and Influenza A Virus Insertional
Mutation Data Sets
Previously published data sets were downloaded from the supplemental
materials of Beitzel et al. (2010), Heaton et al. (2013) and Remenyi et al.
(2014). For VEEV, the 30C data set was used (Beitzel et al., 2010). For the
MeV, HCV, and VEEV data, insertion positions containing >0.01% of total
reads were deemed ‘‘hits’’ and divided by the size of the genomic region.
For the influenza A virus data, discreet insertion positions in the coding regions
(i.e., at least one nucleotide away from a previous ‘‘hit’’ location)R93 above
background were deemed hits and similarly normalized. For the influenza
A virus HA domain analysis, HA1 was defined as the region between nucleo-
tides 81 and 1,121 and HA2 was defined as 1,122–1,730. For the HCV E2
domain analysis, the hyper-variable domain 1was defined as the first 81 nucle-
otides of the E2-coding region.
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